Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - AMEXDRUG CORPFinancial_Report.xls
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES- OXLEY ACT OF 2002 - AMEXDRUG CORPamexdrug10kexh312.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES- OXLEY ACT OF 2002 - AMEXDRUG CORPamexdrug10kexh311.htm
EX-10.13 - FIRST AMENDMENT TO LEASE EXTENDING LEASE TERM (UNITS I&J) DATED JANUARY 18, 2012 - AMEXDRUG CORPamexdrug10kexh1013.htm
EX-10.14 - CHANGE IN TERMS AGREEMENT WITH NATIONAL BANK OF CALIFORNIA DATED DECEMBER 21, 2011 - AMEXDRUG CORPamexdrug10kexh1014.htm
10-K - AMEXDRUG CORPORATION 10K 2011-12-31 - AMEXDRUG CORPamexdrug10k20111231.htm
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 OF THE SARBANES- OXLEY ACT OF 2002 - AMEXDRUG CORPamexdrug10kexh321.htm



EXHIBIT 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 

In connection with the Annual Report of Amexdrug Corporation (the “Company”) on Form 10-K for the period ending December 31, 2011, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jack Amin, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

 
(1)
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 
(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


_/s/ Jack Amin
Jack Amin
Chief Financial Officer
March 30, 2012